← All indications
Heartburn
Substernal pain or burning sensation, usually associated with regurgitation of gastric juice into the esophagus.
Drugs by status
Approved for this indication (18)
Phase 4 trials (7)
Phase 3 trials (4)
Phase 2 trials (2)
Phase 1 trials (2)
Organizations
Organization Involved with Phase 4 Indications (22)
- Eisai
- TAP Pharmaceuticals
- AstraZeneca
- Pfizer
- Wyeth
- Bayer
- Parexel
- TTY Biopharm
- Case Western Reserve University
- Chang Gung University
- Chulalongkorn University
- Katholieke Universiteit Leuven
- University of Heidelberg
- Yonsei University
- University of Cincinnati
- CJ HealthCare Corp.
- University of Mannheim
- American University of Beirut
- Department of Veteran Affairs
- Johnson and Johnson
- University of Helsinki
- IQVIA
Organization Involved with Phase 3 Indications (11)
Organization Involved with Phase 2 Indications (3)
Organization Involved with Phase 1 Indications (4)
Organization Involved with Other Experimental Indications (2)